In 2020, lung cancer, the foremost cause of global cancer-related deaths, took 1.7 million lives, surpassing fatalities from the next three deadliest cancers combined. Early detection significantly improves the five-year survival rate, increasing from…
Continue Reading
Effective breast cancer screening is vital in reducing mortality rates among women. This study explores the optimal age to commence screening and the frequency for maximum benefits. By analyzing data from the Cancer Intervention…
Continue Reading
China Medical University Hospital is leveraging Google Cloud’s generative AI to support its doctors in providing cancer care.A formal collaboration between CMUH and Google Cloud was signed in December last year to use MedLM,…
Continue Reading
Docobo technology is being used by the Medical University of Vienna to remotely monitor cancer patients’ symptoms while they undergo treatment.The haematology outpatient clinic at the Medical University of Vienna, is using the DOC@HOME…
Continue Reading
What You Should Know:
Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) clearance from the United States (U.S.) Food and Drug Administration (FDA) for its Concentriq® AP-Dx*. The digital pathology solution…
Continue Reading
Merit Medical Systems has achieved FDA clearance for its groundbreaking SCOUT MD Surgical Guidance System, a significant advancement in breast cancer care. This innovative system enhances tumor localization with precise accuracy, reducing the need…
Continue Reading
The All India Institute Of Medical Science in New Delhi recently unveiled its new AI solution that assists with the early detection of cancer. Developed with the Centre for Development of Advanced Computing, Pune under the Ministry…
Continue Reading
Vessi Medical, which offers cryotherapy technology to treat non muscle invasive bladder cancer (NMIBC), announced it closed a $16.5 million Series A funding round.The company offers a cryo spray for hollow and humid organs,…
Continue Reading
What You Should Know:
– Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was…
Continue Reading
What You Should Know: InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of an orally bioavailable preclinical candidate compound. This compound targets KIF18A and aims to treat…
Continue Reading
